Table 5.
Changes in primary and secondary outcomes at follow-up
| Outcome | Intervention n = 86 | Comparator group n = 87 | p-value |
|---|---|---|---|
| Exacerbationsa | |||
| Patients with event | 54 (63.5%) | 75 (86.2%) | 0.001 |
| Exacerbations/patient year (median, IQR) | 2 (0–6) | 6 (4–10) | <0.001 |
| Respiratory hospitalisations | |||
| Patients with event | 39 (45.3%) | 66 (76.7%) | <0.001 |
| Days in hospital/patient year (median, IQR) | 0 (0–10.29) | 9.48 (0–30.02) | <0.001 |
| Respiratory admissions/patient year (median (IQR) | 0 (0–2.1) | 1.6 (0–3.6) | <0.001 |
| Cost per year (mean (SD)) | £32390 (£77607) | £53946 (£66748) | – |
n% unless otherwise stated
aMissing values:n = 1